PSEUDOEPHEDRINE HYDROCHLORIDE

PSEUDOEPHEDRINE HYDROCHLORIDE was reported 20410 times

PSEUDOEPHEDRINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SWOLLEN JOINT COUNT INCREASED 1748 0.5476
1 RHEUMATIC FEVER 2354 0.5276
2 HEPATIC ENZYME 78 0.5235
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3609 0.5032
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 329 0.4925
5 LUPUS VULGARIS 587 0.4659
6 RHEUMATOID FACTOR POSITIVE 2543 0.4398
7 DEEP VEIN THROMBOSIS POSTOPERATIVE 873 0.4358
8 DUODENAL ULCER PERFORATION 3122 0.4194
9 PEMPHIGUS 5166 0.4128
10 C-REACTIVE PROTEIN 334 0.3603
11 HAND DEFORMITY 4543 0.3460
12 FACET JOINT SYNDROME 1108 0.3400
13 HYPOCHOLESTEROLAEMIA 119 0.3371
14 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 7 0.3043
15 HELICOBACTER INFECTION 3041 0.2956
16 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 608 0.2932
17 RETINITIS 504 0.2915
18 HYPERSPLENISM ACQUIRED 2 0.2857
19 X-RAY ABNORMAL 501 0.2799
20 DISLOCATION OF VERTEBRA 636 0.2786
21 SWOLLEN JOINT COUNT 65 0.2600
22 PERICARDITIS 4300 0.2557
23 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 143 0.2549
24 MUSCLE INJURY 2074 0.2501
25 PERIPHERAL VENOUS DISEASE 992 0.2427
26 SERONEGATIVE ARTHRITIS 274 0.2391
27 SYNOVITIS 4288 0.2376
28 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 24 0.2286
29 FOLLICULITIS 2362 0.2250
30 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1403 0.2158
31 GLOSSODYNIA 4834 0.2157
32 GRIP STRENGTH 42 0.1834
33 WOUND 4669 0.1669
34 TENDER JOINT COUNT 14 0.1667
35 C-REACTIVE PROTEIN ABNORMAL 1026 0.1598
36 ACQUIRED PORPHYRIA 11 0.1549
37 SYSTEMIC LUPUS ERYTHEMATOSUS 5288 0.1488
38 BREAST CANCER STAGE III 903 0.1393
39 ONYCHOMADESIS 580 0.1381
40 NAIL OPERATION 55 0.1329
41 DRUG TOLERANCE DECREASED 372 0.1323
42 CONTRAINDICATED PRODUCT ADMINISTERED 3940 0.1300
43 BONE EROSION 459 0.1297
44 LIP DRY 1099 0.1209
45 BLEPHAROSPASM 737 0.1169
46 LIVE BIRTH 921 0.1100
47 PORPHYRIA ACUTE 157 0.1094
48 IRRITABLE BOWEL SYNDROME 2301 0.1072
49 OVERLAP SYNDROME 74 0.1057
50 DEATH NEONATAL 146 0.1049
51 WOUND INFECTION 1132 0.1033
52 ONYCHOMYCOSIS 452 0.1029
53 GRIP STRENGTH DECREASED 900 0.1022
54 HYPERCHOLESTEROLAEMIA 986 0.1020
55 JOINT RANGE OF MOTION DECREASED 1331 0.0991
56 BURSITIS 1142 0.0940
57 AUTOIMMUNE DISORDER 832 0.0853
58 LIVER INJURY 2015 0.0820
59 FIBROMYALGIA 1926 0.0791
60 TYPE 2 DIABETES MELLITUS 2630 0.0780
61 ARTHROPATHY 4279 0.0769
62 IMPAIRED HEALING 2284 0.0695
63 NAIL DISORDER 602 0.0687
64 INFUSION RELATED REACTION 4163 0.0627
65 INFUSION SITE REACTION 184 0.0615
66 THERAPEUTIC PRODUCT EFFECT DECREASED 2740 0.0611
67 DISCOMFORT 3728 0.0610
68 PSORIATIC ARTHROPATHY 2448 0.0603
69 OBESITY 954 0.0598
70 JOINT DESTRUCTION 89 0.0572
71 EXOSTOSIS 517 0.0566
72 HIP ARTHROPLASTY 866 0.0565
73 SCIATICA 901 0.0565
74 HEPATIC ENZYME INCREASED 3822 0.0560
75 MATERNAL EXPOSURE TIMING UNSPECIFIED 208 0.0553
76 PRESCRIBED OVERDOSE 1020 0.0527
77 BLOOD CHOLESTEROL INCREASED 2451 0.0525
78 LUPUS-LIKE SYNDROME 475 0.0523
79 FINGER DEFORMITY 246 0.0507
80 DELUSION OF REPLACEMENT 5 0.0500
81 SWELLING 4629 0.0494
82 RED BLOOD CELL SEDIMENTATION RATE INCREASED 545 0.0492
83 PULMONARY FIBROSIS 934 0.0486
84 WALKING AID USER 317 0.0480
85 BLISTER 2613 0.0465
86 RHEUMATOID ARTHRITIS 5167 0.0455
87 LOWER LIMB FRACTURE 866 0.0450
88 LOWER RESPIRATORY TRACT INFECTION 2023 0.0444
89 EYE INJURY 133 0.0437
90 BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS 7 0.0435
91 VAGINAL FLATULENCE 13 0.0429
92 MATERNAL EXPOSURE DURING PREGNANCY 3825 0.0429
93 MUSCULOSKELETAL DEFORMITY 10 0.0427
94 PRODUCT LABEL CONFUSION 247 0.0423
95 PUSTULAR PSORIASIS 144 0.0419
96 BREAST CANCER STAGE II 345 0.0414
97 ULCER HAEMORRHAGE 275 0.0406
98 PRESCRIBED UNDERDOSE 801 0.0401
99 SPONDYLITIS 146 0.0401
100 DRUG INTOLERANCE 3784 0.0391
101 BACK INJURY 422 0.0388
102 JOINT DISLOCATION 407 0.0385
103 KNEE ARTHROPLASTY 799 0.0379
104 TREATMENT FAILURE 3015 0.0364
105 STOMATITIS 2203 0.0363
106 RED BLOOD CELL SEDIMENTATION RATE 10 0.0358
107 FOOT DEFORMITY 394 0.0355
108 CONGENITAL ANOMALY 274 0.0354
109 GAIT INABILITY 1180 0.0353
110 TASTE DISORDER 681 0.0335
111 INCISION SITE RASH 2 0.0333
112 JOINT SWELLING 4011 0.0332
113 COELIAC DISEASE 323 0.0329
114 NIGHT SWEATS 1059 0.0328
115 OSTEOARTHRITIS 1320 0.0311
116 ANTIPHOSPHOLIPID ANTIBODIES 6 0.0308
117 ABDOMINAL DISCOMFORT 5082 0.0303
118 RASH VESICULAR 141 0.0291
119 MOBILITY DECREASED 2080 0.0289
120 C-REACTIVE PROTEIN INCREASED 1035 0.0284
121 INJURY 1987 0.0282
122 WHEEZING 1675 0.0282
123 MUSCULOSKELETAL STIFFNESS 2440 0.0278
124 ILL-DEFINED DISORDER 1623 0.0267
125 NORMAL NEWBORN 145 0.0266
126 DRUG TOLERANCE 132 0.0261
127 PERFORATION 21 0.0261
128 SPINAL FUSION SURGERY 103 0.0254
129 ALOPECIA 4951 0.0252
130 GENERAL PHYSICAL HEALTH DETERIORATION 2908 0.0251
131 LIVER FUNCTION TEST INCREASED 535 0.0249
132 EXPOSURE DURING PREGNANCY 1539 0.0247
133 HEPATIC CIRRHOSIS 455 0.0242
134 INTENTIONAL PRODUCT USE ISSUE 2102 0.0240
135 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 401 0.0234
136 ROAD TRAFFIC ACCIDENT 962 0.0230
137 EPILEPSY 690 0.0225
138 OEDEMA 1217 0.0224
139 LUNG DISORDER 1098 0.0224
140 INFLAMMATION 1141 0.0221
141 ANKLE ARTHROPLASTY 8 0.0220
142 SLEEP DISORDER 1503 0.0213
143 BLOOD CHOLESTEROL 10 0.0211
144 HYPERSENSITIVITY 3904 0.0210
145 ANAL INFLAMMATION 13 0.0203
146 PREGNANCY 392 0.0196
147 GASTROINTESTINAL DISORDER 1735 0.0193
148 THERAPY NON-RESPONDER 870 0.0193
149 SARS-COV-2 TEST NEGATIVE 13 0.0193
150 MUSCULOSKELETAL PAIN 972 0.0185
151 EPIDERMAL NECROSIS 18 0.0185
152 JOINT STIFFNESS 483 0.0184
153 DELIRIUM 634 0.0182
154 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 42 0.0182
155 PRODUCT USE ISSUE 3425 0.0182
156 RHEUMATOID VASCULITIS 4 0.0178
157 HYPER IGE SYNDROME 2 0.0175
158 SINUSITIS 1771 0.0173
159 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 9 0.0172
160 DELUSIONAL PERCEPTION 7 0.0169
161 LIVER DISORDER 744 0.0168
162 GENERAL SYMPTOM 124 0.0165
163 DRY MOUTH 1297 0.0160
164 CONTUSION 1525 0.0158
165 MYOSITIS 141 0.0157
166 ADVERSE REACTION 208 0.0157
167 DRUG-INDUCED LIVER INJURY 481 0.0153
168 THUNDERCLAP HEADACHE 4 0.0153
169 POLYARTHRITIS 79 0.0150
170 DISABILITY 294 0.0149
171 BREAST ULCERATION 2 0.0144
172 PERIPHERAL SWELLING 2132 0.0138
173 CONFUSIONAL STATE 2232 0.0138
174 INFECTION 1978 0.0137
175 EAR INFECTION 363 0.0136
176 HYPOAESTHESIA 1935 0.0129
177 REPETITIVE SPEECH 7 0.0124
178 VASCULAR ACCESS COMPLICATION 10 0.0123
179 CYCLIC VOMITING SYNDROME 9 0.0123
180 EAR PAIN 238 0.0122
181 MIGRAINE 1156 0.0121
182 PARANASAL SINUS HYPOSECRETION 3 0.0120
183 NASOPHARYNGITIS 2181 0.0118
184 ADVERSE EVENT 1078 0.0117
185 HYPERTENSION 2378 0.0112
186 OSTEOPOROSIS 458 0.0111
187 FEMALE GENITAL TRACT FISTULA 19 0.0111
188 URTICARIA 1856 0.0111
189 DYSPEPSIA 1078 0.0109
190 MEAN PLATELET VOLUME DECREASED 9 0.0107
191 DAIRY INTOLERANCE 3 0.0107
192 ADMINISTRATION SITE DISCOMFORT 2 0.0106
193 RASH 4576 0.0105
194 WEIGHT INCREASED 2318 0.0103
195 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 729 0.0102
196 EXPOSURE TO UNSPECIFIED AGENT 2 0.0102
197 GASTROOESOPHAGEAL REFLUX DISEASE 801 0.0099
198 ADVERSE DRUG REACTION 881 0.0098
199 CONDITION AGGRAVATED 2879 0.0095
200 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 453 0.0094
201 BRONCHIAL OBSTRUCTION 13 0.0093
202 HEPATITIS 236 0.0092
203 TENOSYNOVITIS STENOSANS 5 0.0090
204 MEDICATION ERROR 497 0.0089
205 JOINT ARTHROPLASTY 16 0.0089
206 AMNESIA 581 0.0089
207 SYNOVIAL DISORDER 4 0.0088
208 RESPIRATORY DISORDER 262 0.0087
209 PAIN 5244 0.0085
210 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 144 0.0085
211 KIDNEY DUPLEX 2 0.0083
212 OESOPHAGEAL MOTILITY DISORDER 3 0.0083
213 MEMORY IMPAIRMENT 1146 0.0083
214 CARCINOID TUMOUR PULMONARY 2 0.0083
215 FREQUENT BOWEL MOVEMENTS 219 0.0081
216 ASTHMA 916 0.0081
217 HYPERTRANSAMINASAEMIA 56 0.0080
218 SUSPECTED OFF LABEL USE 36 0.0080
219 ABDOMINAL PAIN UPPER 1581 0.0077
220 RADICULOPATHY 20 0.0076
221 NECK PAIN 422 0.0075
222 ARTHRALGIA 3113 0.0075
223 MUSCULAR WEAKNESS 845 0.0074
224 CRANIOTOMY 3 0.0073
225 PRODUCT USE IN UNAPPROVED INDICATION 1801 0.0073
226 OCCIPITAL NEURALGIA 4 0.0071
227 BACK DISORDER 115 0.0071
228 UPPER RESPIRATORY TRACT INFECTION 326 0.0070
229 DECREASED APPETITE 1605 0.0069
230 EXPOSURE TO TOXIC AGENT 22 0.0069
231 WEIGHT FLUCTUATION 70 0.0067
232 PARAESTHESIA 1033 0.0066
233 ADRENAL INSUFFICIENCY 79 0.0065
234 MITE ALLERGY 4 0.0061
235 FATIGUE 4653 0.0060
236 VITAMIN B12 DECREASED 17 0.0059
237 CAROTID ARTERY ANEURYSM 2 0.0058
238 CHEST PAIN 1084 0.0058
239 MEAN CELL VOLUME DECREASED 9 0.0058
240 OEDEMA PERIPHERAL 710 0.0058
241 UNDERDOSE 408 0.0056
242 PYREXIA 1910 0.0055
243 IMMUNODEFICIENCY 82 0.0055
244 INCREASED BRONCHIAL SECRETION 14 0.0055
245 MEAN CELL HAEMOGLOBIN DECREASED 10 0.0055
246 MUSCLE SPASMS 993 0.0054
247 GENERALISED BULLOUS FIXED DRUG ERUPTION 2 0.0054
248 MUSCLE SPASTICITY 66 0.0054
249 NASAL TURBINATE HYPERTROPHY 2 0.0053
250 INJECTION SITE REACTION 363 0.0053
251 MYCOBACTERIAL INFECTION 9 0.0052
252 ARTHRITIS 395 0.0050
253 PROCTITIS 14 0.0050
254 INCORRECT PRODUCT ADMINISTRATION DURATION 108 0.0050
255 GAIT DISTURBANCE 939 0.0049
256 LICHENIFICATION 2 0.0049
257 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 4 0.0049
258 REACTION TO COLOURING 2 0.0049
259 PRODUCT QUALITY ISSUE 655 0.0048
260 CHRONIC SINUSITIS 18 0.0048
261 DEPRESSION 1080 0.0047
262 THERAPEUTIC RESPONSE DECREASED 286 0.0047
263 COLITIS ULCERATIVE 209 0.0047
264 INSOMNIA 1229 0.0046
265 BLOOD IMMUNOGLOBULIN A DECREASED 3 0.0046
266 PAIN IN EXTREMITY 1349 0.0046
267 PRURITUS 1753 0.0046
268 MACULAR DEGENERATION 54 0.0045
269 VOMITING 2092 0.0044
270 VISUAL IMPAIRMENT 546 0.0044
271 MATERNAL EXPOSURE BEFORE PREGNANCY 30 0.0044
272 ALLERGY TO PLANTS 2 0.0044
273 PNEUMONIA 1396 0.0043
274 ECZEMA ASTEATOTIC 2 0.0042
275 OFF LABEL USE 3701 0.0042
276 RECTAL HAEMORRHAGE 180 0.0042
277 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11 0.0041
278 CEREBRAL ARTERY STENOSIS 2 0.0041
279 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 8 0.0040
280 CARDIAC INFECTION 3 0.0040
281 DRUG INEFFECTIVE 5213 0.0040
282 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 28 0.0039
283 HEADACHE 2362 0.0038
284 MALAISE 1603 0.0037
285 MULTIPLE ALLERGIES 28 0.0036
286 CRYPTORCHISM 4 0.0036
287 INFECTED BITE 3 0.0035
288 ALLERGIC SINUSITIS 3 0.0035
289 FEELING HOT 213 0.0035
290 DUODENAL ULCER 24 0.0034
291 HYPERTENSIVE EMERGENCY 4 0.0034
292 AMBLYOPIA 2 0.0034
293 DIZZINESS 1683 0.0034
294 ASTHENIA 1258 0.0033
295 DYSPNOEA 1880 0.0033
296 MONOCYTE COUNT INCREASED 12 0.0033
297 ASPARTATE AMINOTRANSFERASE ABNORMAL 5 0.0033
298 EXCESSIVE CERUMEN PRODUCTION 2 0.0032
299 FOETAL EXPOSURE DURING PREGNANCY 260 0.0032
300 ABDOMINAL PAIN 742 0.0032
301 PAROTID GLAND ENLARGEMENT 2 0.0031
302 NODULE 40 0.0031
303 DUST ALLERGY 3 0.0031
304 PSORIASIS 387 0.0030
305 STARING 7 0.0029
306 ABDOMINAL DISTENSION 301 0.0029
307 MENISCUS LESION 4 0.0029
308 THERAPEUTIC PRODUCT EFFECT DELAYED 13 0.0028
309 TACHYCARDIA 250 0.0028
310 LABORATORY TEST ABNORMAL 83 0.0028
311 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 17 0.0028
312 CARDIAC SEPTAL DEFECT 2 0.0028
313 DIARRHOEA 1792 0.0028
314 CEREBRAL VASOCONSTRICTION 2 0.0027
315 FLUID RETENTION 137 0.0027
316 PANCREATITIS 142 0.0027
317 WEIGHT DECREASED 749 0.0027
318 BODY TEMPERATURE INCREASED 53 0.0026
319 WHITE BLOOD CELL COUNT INCREASED 99 0.0026
320 PNEUMONIA MYCOPLASMAL 2 0.0025
321 BRONCHITIS 184 0.0025
322 ANXIETY 696 0.0024
323 ALTERED VISUAL DEPTH PERCEPTION 2 0.0024
324 SEBORRHOEIC DERMATITIS 4 0.0024
325 CIRCADIAN RHYTHM SLEEP DISORDER 2 0.0024
326 NAUSEA 1898 0.0024
327 GASTROENTERITIS VIRAL 43 0.0024
328 HYPERVENTILATION 13 0.0022
329 DRUG DETOXIFICATION 2 0.0022
330 TOXIC EPIDERMAL NECROLYSIS 34 0.0022
331 PROCTALGIA 14 0.0022
332 JOINT EFFUSION 15 0.0022
333 NEONATAL RESPIRATORY DISTRESS 2 0.0021
334 ASPIRATION 23 0.0021
335 HYPERVIGILANCE 2 0.0021
336 RASH PRURITIC 111 0.0020
337 PHYSICAL DISABILITY 9 0.0020
338 HYPOCALCAEMIA 38 0.0020
339 HAEMORRHAGIC DIATHESIS 7 0.0020
340 BLOOD PRESSURE DIASTOLIC INCREASED 9 0.0019
341 EYE ALLERGY 3 0.0019
342 BONE DEMINERALISATION 2 0.0019
343 TINEA PEDIS 3 0.0019
344 PROTEIN TOTAL INCREASED 5 0.0019
345 SCLERITIS 3 0.0019
346 RHINITIS 15 0.0019
347 HOSPITALISATION 285 0.0019
348 SYMPTOM RECURRENCE 11 0.0018
349 SPINAL CORD DISORDER 3 0.0018
350 FOOT OPERATION 9 0.0018
351 PHOBIA 2 0.0017
352 BLOODY DISCHARGE 2 0.0017
353 MOVEMENT DISORDER 56 0.0017
354 CERVICAL SPINAL STENOSIS 3 0.0017
355 TREATMENT NONCOMPLIANCE 95 0.0017
356 HYPOKALAEMIA 79 0.0017
357 RESTRICTIVE PULMONARY DISEASE 2 0.0017
358 INCISION SITE PAIN 2 0.0017
359 SCHIZOAFFECTIVE DISORDER 3 0.0017
360 VAGINAL DISCHARGE 17 0.0017
361 URINE FLOW DECREASED 4 0.0017
362 RESPIRATORY TRACT INFECTION 43 0.0016
363 ALLERGY TO CHEMICALS 2 0.0016
364 PRODUCT USED FOR UNKNOWN INDICATION 2 0.0016
365 PARANASAL SINUS DISCOMFORT 6 0.0016
366 WHEELCHAIR USER 7 0.0016
367 ULCER 25 0.0016
368 SKIN REACTION 22 0.0016
369 FOREIGN BODY IN RESPIRATORY TRACT 2 0.0015
370 ANAPHYLACTIC REACTION 84 0.0015
371 LEUKOPENIA 76 0.0015
372 DRUG SCREEN POSITIVE 12 0.0015
373 ARTHRITIS INFECTIVE 7 0.0015
374 RASH PAPULAR 33 0.0015
375 CLONUS 4 0.0015
376 JAW DISORDER 8 0.0015
377 CORNEAL ABRASION 2 0.0015
378 RHEUMATOID NODULE 4 0.0015
379 RENAL ARTERY STENOSIS 2 0.0015
380 FUNCTIONAL GASTROINTESTINAL DISORDER 5 0.0014
381 PRE-EXISTING CONDITION IMPROVED 9 0.0014
382 CATAPLEXY 2 0.0014
383 DYSPHORIA 7 0.0014
384 OESOPHAGEAL VARICES HAEMORRHAGE 3 0.0014
385 LIMB DISCOMFORT 42 0.0014
386 CREPITATIONS 4 0.0013
387 BRONCHIECTASIS 9 0.0013
388 PREGNANCY AFTER POST COITAL CONTRACEPTION 3 0.0013
389 CEREBROVASCULAR DISORDER 4 0.0013
390 PNEUMONIA PSEUDOMONAL 2 0.0013
391 CALCULUS URINARY 2 0.0013
392 POLYCYSTIC OVARIES 2 0.0013
393 BRONCHIAL DISORDER 2 0.0013
394 DRUG EFFECT LESS THAN EXPECTED 19 0.0013
395 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0013
396 URINARY HESITATION 3 0.0013
397 SCREAMING 8 0.0013
398 PARAESTHESIA ORAL 18 0.0012
399 CUSHINGOID 4 0.0012
400 ACCIDENT 14 0.0012
401 OBSTRUCTIVE AIRWAYS DISORDER 13 0.0012
402 RETINAL DISORDER 3 0.0012
403 TENDERNESS 12 0.0012
404 PAPILLARY THYROID CANCER 2 0.0011
405 ORAL CANDIDIASIS 15 0.0011
406 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 62 0.0011
407 RHINITIS ALLERGIC 5 0.0011
408 GAMBLING DISORDER 3 0.0011
409 CLUMSINESS 3 0.0011
410 WRONG PATIENT RECEIVED MEDICATION 3 0.0011
411 TYPE IV HYPERSENSITIVITY REACTION 3 0.0011
412 CONTRAST MEDIA ALLERGY 2 0.0011
413 PNEUMONIA KLEBSIELLA 2 0.0011
414 PLEURITIC PAIN 3 0.0011
415 INTENTIONAL PRODUCT MISUSE 95 0.0011
416 BREAST CANCER STAGE I 10 0.0011
417 MIDDLE INSOMNIA 20 0.0011
418 DEFORMITY 10 0.0011
419 NASAL OBSTRUCTION 2 0.0011
420 NARCOLEPSY 2 0.0011
421 SEASONAL ALLERGY 15 0.0011
422 FORCED EXPIRATORY VOLUME DECREASED 3 0.0011
423 APPETITE DISORDER 7 0.0011
424 SPINAL DISORDER 10 0.0011
425 FEELING JITTERY 20 0.0010
426 PATIENT DISSATISFACTION WITH TREATMENT 2 0.0010
427 SNEEZING 23 0.0010
428 CONJUNCTIVITIS 19 0.0010
429 WRONG DRUG ADMINISTERED 9 0.0010
430 OVERDOSE 215 0.0010
431 SEPTIC SHOCK 43 0.0010
432 INTERNATIONAL NORMALISED RATIO FLUCTUATION 2 0.0010
433 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 28 0.0010
434 DEREALISATION 2 0.0009
435 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0009
436 PLATELET COUNT INCREASED 12 0.0009
437 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
438 OLIGOMENORRHOEA 2 0.0009
439 EXPIRED PRODUCT ADMINISTERED 30 0.0009
440 WRONG PRODUCT ADMINISTERED 6 0.0009
441 EAR DISORDER 4 0.0009
442 GRANULOMA 3 0.0009
443 TACHYPHRENIA 3 0.0009
444 THROMBOTIC THROMBOCYTOPENIC PURPURA 3 0.0009
445 FALL 283 0.0008
446 ENERGY INCREASED 5 0.0008
447 SINUS HEADACHE 5 0.0008
448 GASTROINTESTINAL TOXICITY 4 0.0008
449 LOSS OF CONSCIOUSNESS 106 0.0008
450 SCLERODERMA 3 0.0008
451 MAJOR DEPRESSION 6 0.0008
452 HAEMATOLOGICAL INFECTION 2 0.0008
453 DRUG TOXICITY 11 0.0008
454 THROMBOCYTOPENIA 90 0.0008
455 INTRAVENTRICULAR HAEMORRHAGE 2 0.0008
456 HEPATIC ENZYME ABNORMAL 4 0.0008
457 EOSINOPHILIA 14 0.0008
458 SNORING 3 0.0008
459 EXCORIATION 2 0.0008
460 PHLEBITIS 4 0.0008
461 OPTIC ISCHAEMIC NEUROPATHY 3 0.0008
462 RASH ERYTHEMATOUS 37 0.0008
463 ACTINIC KERATOSIS 2 0.0008
464 ACCIDENTAL OVERDOSE 28 0.0008
465 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
466 GASTRIC DISORDER 26 0.0008
467 NASAL DISORDER 2 0.0008
468 THINKING ABNORMAL 14 0.0008
469 ARTERIOSPASM CORONARY 3 0.0007
470 DIABETES MELLITUS 57 0.0007
471 EAR CONGESTION 2 0.0007
472 MIGRAINE WITH AURA 2 0.0007
473 SLEEP APNOEA SYNDROME 14 0.0007
474 RHINALGIA 2 0.0007
475 URINARY RETENTION 24 0.0007
476 HAEMORRHOIDS 14 0.0007
477 THERAPEUTIC RESPONSE UNEXPECTED 32 0.0007
478 PERIORBITAL SWELLING 4 0.0007
479 PULMONARY TOXICITY 5 0.0007
480 PHARYNGEAL DISORDER 2 0.0007
481 HORDEOLUM 3 0.0007
482 PRODUCTIVE COUGH 33 0.0007
483 PHOTOPHOBIA 13 0.0007
484 COMA SCALE ABNORMAL 2 0.0007
485 SKIN WARM 4 0.0007
486 PULMONARY PAIN 2 0.0007
487 BLOOD CREATINE INCREASED 3 0.0007
488 RESPIRATORY RATE INCREASED 6 0.0007
489 PLEURAL EFFUSION 41 0.0007
490 SINUS CONGESTION 9 0.0007
491 CENTRAL VENOUS CATHETERISATION 2 0.0007
492 PERIPHERAL COLDNESS 9 0.0007
493 BODY HEIGHT DECREASED 7 0.0007
494 POOR QUALITY SLEEP 14 0.0006
495 SYNOVIAL CYST 3 0.0006
496 PORTAL HYPERTENSION 2 0.0006
497 NEPHROGENIC ANAEMIA 3 0.0006
498 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
499 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
500 DERMATITIS CONTACT 7 0.0006
501 NASAL POLYPS 3 0.0006
502 LYME DISEASE 2 0.0006
503 DYSLIPIDAEMIA 3 0.0006
504 PERIPHERAL VASCULAR DISORDER 3 0.0006
505 MUSCLE STRAIN 5 0.0006
506 PROCEDURAL PAIN 16 0.0006
507 NERVOUSNESS 30 0.0006
508 MACULOPATHY 2 0.0006
509 RESTLESS LEGS SYNDROME 10 0.0005
510 FOOD INTOLERANCE 2 0.0005
511 ARTHROPOD BITE 4 0.0005
512 HEPATOTOXICITY 12 0.0005
513 ACUTE PULMONARY OEDEMA 3 0.0005
514 IMPULSIVE BEHAVIOUR 2 0.0005
515 INCORRECT DOSE ADMINISTERED 121 0.0005
516 PALPITATIONS 61 0.0005
517 NO ADVERSE EVENT 93 0.0005
518 URINE ODOUR ABNORMAL 3 0.0005
519 ERECTILE DYSFUNCTION 13 0.0005
520 HOMICIDAL IDEATION 2 0.0005
521 TOOTH ABSCESS 5 0.0005
522 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
523 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
524 EYE DISCHARGE 5 0.0005
525 NASAL DRYNESS 3 0.0005
526 NASAL CONGESTION 28 0.0005
527 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
528 COLITIS 18 0.0005
529 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
530 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
531 ABSCESS LIMB 2 0.0005
532 INCORRECT DRUG ADMINISTRATION DURATION 13 0.0005
533 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 83 0.0005
534 TENDON DISORDER 3 0.0005
535 POST-TRAUMATIC STRESS DISORDER 3 0.0004
536 IRON DEFICIENCY 2 0.0004
537 COLITIS ISCHAEMIC 3 0.0004
538 PRODUCT LABEL ISSUE 3 0.0004
539 DISEASE RECURRENCE 21 0.0004
540 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
541 ABDOMINAL HERNIA 2 0.0004
542 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
543 RESPIRATION ABNORMAL 3 0.0004
544 DYSURIA 16 0.0004
545 LYMPHOEDEMA 3 0.0004
546 EYELID OEDEMA 5 0.0004
547 ROSACEA 2 0.0004
548 ERYTHEMA MULTIFORME 4 0.0004
549 FLANK PAIN 4 0.0004
550 BLOOD PRESSURE INCREASED 65 0.0004
551 HAND FRACTURE 3 0.0004
552 HYPOVOLAEMIC SHOCK 2 0.0004
553 SEROTONIN SYNDROME 8 0.0004
554 DEEP VEIN THROMBOSIS 27 0.0004
555 VISUAL FIELD DEFECT 3 0.0004
556 HUMERUS FRACTURE 2 0.0004
557 ATELECTASIS 4 0.0004
558 HAEMOGLOBIN DECREASED 42 0.0004
559 INFLAMMATORY BOWEL DISEASE 4 0.0004
560 SPINAL OPERATION 5 0.0004
561 BREATH SOUNDS ABNORMAL 2 0.0004
562 MUCOUS STOOLS 2 0.0004
563 ORAL PAIN 9 0.0004
564 BACK PAIN 93 0.0004
565 SECRETION DISCHARGE 5 0.0004
566 OSTEOPENIA 6 0.0004
567 EUPHORIC MOOD 4 0.0004
568 EMOTIONAL DISORDER 12 0.0004
569 TEMPERATURE INTOLERANCE 4 0.0004
570 ANKLE FRACTURE 6 0.0004
571 UNRESPONSIVE TO STIMULI 10 0.0004
572 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
573 PERIORBITAL OEDEMA 2 0.0004
574 MALABSORPTION 2 0.0004
575 BRAIN FOG 6 0.0004
576 SEDATION 10 0.0004
577 CATATONIA 2 0.0004
578 HAEMATOCHEZIA 21 0.0004
579 TOOTH INFECTION 5 0.0004
580 BLOOD DISORDER 3 0.0004
581 FOOD POISONING 2 0.0004
582 OVERWEIGHT 2 0.0004
583 INTERSTITIAL LUNG DISEASE 18 0.0004
584 GINGIVITIS 2 0.0004
585 IMPAIRED GASTRIC EMPTYING 5 0.0004
586 HICCUPS 3 0.0004
587 DENTAL CARIES 4 0.0004
588 INTRACRANIAL PRESSURE INCREASED 2 0.0004
589 CARPAL TUNNEL SYNDROME 5 0.0004
590 SKIN INFECTION 4 0.0004
591 SENSATION OF FOREIGN BODY 3 0.0004
592 CANDIDA INFECTION 6 0.0004
593 PREMATURE LABOUR 2 0.0004
594 CHOLECYSTECTOMY 4 0.0003
595 NEUROLOGICAL SYMPTOM 2 0.0003
596 HYSTERECTOMY 3 0.0003
597 EXTRA DOSE ADMINISTERED 14 0.0003
598 ELECTROLYTE IMBALANCE 4 0.0003
599 HIP FRACTURE 11 0.0003
600 SPINAL OSTEOARTHRITIS 3 0.0003
601 RHINORRHOEA 22 0.0003
602 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
603 HEAD DISCOMFORT 6 0.0003
604 PSYCHOTIC DISORDER 10 0.0003
605 DRUG ERUPTION 6 0.0003
606 THIRST 6 0.0003
607 WHITE BLOOD CELL COUNT DECREASED 36 0.0003
608 ECONOMIC PROBLEM 5 0.0003
609 JOINT INJURY 7 0.0003
610 IMPAIRED WORK ABILITY 7 0.0003
611 ABNORMAL DREAMS 9 0.0003
612 NERVE COMPRESSION 3 0.0003
613 LARYNGEAL OEDEMA 2 0.0003
614 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
615 DEATH 279 0.0003
616 HEART RATE INCREASED 32 0.0003
617 ILLNESS 33 0.0003
618 POISONING 4 0.0003
619 DERMATITIS ALLERGIC 4 0.0003
620 PHOTOPSIA 2 0.0003
621 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
622 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
623 DRUG ABUSE 26 0.0003
624 VITAMIN D DEFICIENCY 3 0.0003
625 HYPOGAMMAGLOBULINAEMIA 2 0.0003
626 SINUS DISORDER 6 0.0003
627 TOXICITY TO VARIOUS AGENTS 51 0.0003
628 PANIC ATTACK 11 0.0003
629 FUNGAL INFECTION 10 0.0003
630 COMPLETED SUICIDE 25 0.0003
631 DRY THROAT 3 0.0003
632 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
633 HYPOTENSION 59 0.0003
634 CHEST DISCOMFORT 30 0.0003
635 EAR DISCOMFORT 3 0.0003
636 HALLUCINATION 22 0.0003
637 ECCHYMOSIS 2 0.0003
638 DROOLING 2 0.0003
639 SCRATCH 3 0.0003
640 DRY EYE 14 0.0003
641 SOMNOLENCE 56 0.0003
642 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
643 EYE DISORDER 9 0.0003
644 RESTLESSNESS 10 0.0003
645 CHILLS 32 0.0003
646 AGITATION 20 0.0003
647 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
648 NERVE INJURY 3 0.0003
649 FEELING DRUNK 2 0.0003
650 ANHEDONIA 7 0.0003
651 PAROSMIA 2 0.0003
652 DEPRESSED MOOD 14 0.0003
653 COUGH 74 0.0003
654 FOOT FRACTURE 5 0.0003
655 VERTIGO 16 0.0003
656 PROCEDURAL COMPLICATION 2 0.0003
657 FOOD ALLERGY 2 0.0003
658 FEELING ABNORMAL 62 0.0003
659 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
660 DELUSION 4 0.0003
661 APNOEA 2 0.0003
662 CHOKING 5 0.0003
663 FEBRILE NEUTROPENIA 17 0.0003
664 BONE DENSITY DECREASED 8 0.0003
665 SKIN LESION 7 0.0003
666 PRODUCT USE COMPLAINT 4 0.0003
667 BLOOD IRON DECREASED 3 0.0003
668 FURUNCLE 2 0.0003
669 CONSTIPATION 55 0.0003
670 RESPIRATORY TRACT CONGESTION 4 0.0003
671 HALLUCINATION, AUDITORY 4 0.0003
672 LOW BIRTH WEIGHT BABY 2 0.0003
673 FEELING COLD 7 0.0003
674 CYSTITIS 8 0.0003
675 BLOOD PRESSURE FLUCTUATION 6 0.0002
676 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
677 PRODUCT ADMINISTRATION ERROR 5 0.0002
678 MUSCLE TIGHTNESS 4 0.0002
679 RESPIRATORY FAILURE 18 0.0002
680 SMALL INTESTINAL OBSTRUCTION 3 0.0002
681 PHARYNGITIS 3 0.0002
682 DRUG LEVEL INCREASED 4 0.0002
683 MYALGIA 41 0.0002
684 HEMIPLEGIA 2 0.0002
685 TINNITUS 11 0.0002
686 BLOOD UREA INCREASED 4 0.0002
687 DERMATITIS 5 0.0002
688 CELLULITIS 12 0.0002
689 DRUG USE DISORDER 2 0.0002
690 FACIAL PARALYSIS 2 0.0002
691 PRODUCT CONTAINER ISSUE 2 0.0002
692 PSEUDOMONAS INFECTION 2 0.0002
693 INFUSION SITE PAIN 3 0.0002
694 PSYCHOLOGICAL TRAUMA 2 0.0002
695 LACRIMATION INCREASED 7 0.0002
696 HIATUS HERNIA 3 0.0002
697 CARDIAC MURMUR 2 0.0002
698 PULMONARY CONGESTION 3 0.0002
699 COLD SWEAT 4 0.0002
700 SWOLLEN TONGUE 7 0.0002
701 HAEMOLYTIC ANAEMIA 2 0.0002
702 DISTURBANCE IN ATTENTION 12 0.0002
703 ANAL INCONTINENCE 2 0.0002
704 TOOTHACHE 4 0.0002
705 HAEMORRHAGE 23 0.0002
706 AGGRESSION 11 0.0002
707 ACUTE HEPATIC FAILURE 3 0.0002
708 END STAGE RENAL DISEASE 4 0.0002
709 BRAIN NEOPLASM 2 0.0002
710 RETINAL DETACHMENT 2 0.0002
711 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 44 0.0002
712 BLOOD GLUCOSE ABNORMAL 4 0.0002
713 DIARRHOEA HAEMORRHAGIC 2 0.0002
714 BLOOD TEST ABNORMAL 3 0.0002
715 INTESTINAL OBSTRUCTION 8 0.0002
716 DIALYSIS 3 0.0002
717 PRODUCT PACKAGING ISSUE 2 0.0002
718 MUSCULOSKELETAL DISORDER 4 0.0002
719 SKIN DISORDER 7 0.0002
720 RED BLOOD CELL COUNT DECREASED 6 0.0002
721 HYPERSOMNIA 6 0.0002
722 IMPAIRED QUALITY OF LIFE 3 0.0002
723 ACUTE RESPIRATORY FAILURE 4 0.0002
724 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
725 KNEE OPERATION 2 0.0002
726 BODY TEMPERATURE DECREASED 2 0.0002
727 NIGHTMARE 7 0.0002
728 LIGAMENT SPRAIN 2 0.0002
729 DYSGEUSIA 15 0.0002
730 HYPERHIDROSIS 26 0.0002
731 BLADDER DISORDER 2 0.0002
732 THROAT IRRITATION 9 0.0002
733 HYPOTONIA 2 0.0002
734 EMPHYSEMA 2 0.0002
735 PRODUCT COMPLAINT 5 0.0002
736 HAEMATEMESIS 5 0.0002
737 EYE PAIN 11 0.0002
738 ERYTHEMA 40 0.0002
739 TENDONITIS 3 0.0002
740 SKIN ULCER 5 0.0002
741 POLLAKIURIA 8 0.0002
742 INTENTIONAL DRUG MISUSE 4 0.0002
743 ECZEMA 10 0.0002
744 SEIZURE 22 0.0002
745 OCULAR HYPERAEMIA 9 0.0002
746 DYSPHAGIA 18 0.0002
747 HALLUCINATION, VISUAL 4 0.0002
748 INCONTINENCE 2 0.0002
749 RENAL PAIN 2 0.0002
750 HYPOTHYROIDISM 6 0.0002
751 EPISTAXIS 14 0.0002
752 SUICIDAL IDEATION 17 0.0002
753 SWELLING FACE 12 0.0002
754 LIMB INJURY 5 0.0002
755 PULMONARY THROMBOSIS 2 0.0002
756 OESOPHAGITIS 2 0.0002
757 SUICIDE ATTEMPT 11 0.0002
758 TREMOR 30 0.0002
759 LIP SWELLING 6 0.0002
760 PULMONARY EMBOLISM 17 0.0002
761 HEMIPARESIS 3 0.0002
762 MITRAL VALVE INCOMPETENCE 2 0.0002
763 DISORIENTATION 7 0.0002
764 IMPAIRED DRIVING ABILITY 2 0.0002
765 MICTURITION URGENCY 2 0.0002
766 LETHARGY 10 0.0002
767 MUSCLE TWITCHING 4 0.0002
768 OROPHARYNGEAL PAIN 16 0.0002
769 NEOPLASM PROGRESSION 6 0.0002
770 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
771 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 12 0.0002
772 ATAXIA 2 0.0002
773 ISCHAEMIC STROKE 3 0.0002
774 HYPERLIPIDAEMIA 2 0.0002
775 SKIN EXFOLIATION 14 0.0002
776 CORONARY ARTERY DISEASE 5 0.0002
777 NOCTURIA 2 0.0002
778 NEURALGIA 4 0.0002
779 THROMBOSIS 13 0.0002
780 EYE SWELLING 6 0.0002
781 ILEUS 2 0.0002
782 BACTERIAL INFECTION 3 0.0002
783 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
784 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
785 ABDOMINAL PAIN LOWER 4 0.0002
786 CHRONIC KIDNEY DISEASE 12 0.0002
787 MUSCLE ATROPHY 2 0.0002
788 MOOD SWINGS 5 0.0002
789 EYE IRRITATION 9 0.0002
790 DRUG PRESCRIBING ERROR 3 0.0002
791 MYDRIASIS 2 0.0002
792 INTENTIONAL OVERDOSE 10 0.0002
793 HERNIA 3 0.0002
794 DIPLOPIA 4 0.0002
795 SKIN FISSURES 3 0.0002
796 INFLUENZA 17 0.0002
797 DERMATITIS ATOPIC 8 0.0002
798 UPPER LIMB FRACTURE 3 0.0002
799 EYE PRURITUS 5 0.0001
800 INTENTIONAL SELF-INJURY 3 0.0001
801 PRODUCT TASTE ABNORMAL 2 0.0001
802 ANAEMIA 28 0.0001
803 AKATHISIA 2 0.0001
804 RESPIRATORY ARREST 4 0.0001
805 MENTAL STATUS CHANGES 4 0.0001
806 HUNGER 2 0.0001
807 CARDIO-RESPIRATORY ARREST 6 0.0001
808 APHONIA 2 0.0001
809 RENAL FAILURE 19 0.0001
810 HEART RATE DECREASED 5 0.0001
811 DEVICE OCCLUSION 2 0.0001
812 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
813 HYPOXIA 5 0.0001
814 BLINDNESS UNILATERAL 2 0.0001
815 LYMPHADENOPATHY 5 0.0001
816 PAIN IN JAW 4 0.0001
817 FLATULENCE 8 0.0001
818 EATING DISORDER 3 0.0001
819 INTENTIONAL DOSE OMISSION 4 0.0001
820 NEUTROPENIA 19 0.0001
821 ANGINA PECTORIS 4 0.0001
822 CARDIOGENIC SHOCK 2 0.0001
823 HERPES ZOSTER 8 0.0001
824 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
825 BALANCE DISORDER 12 0.0001
826 BLOOD CREATININE INCREASED 9 0.0001
827 DRUG EFFECT INCOMPLETE 5 0.0001
828 NEEDLE ISSUE 4 0.0001
829 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
830 HYPERGLYCAEMIA 5 0.0001
831 DYSSTASIA 4 0.0001
832 ASCITES 4 0.0001
833 URINARY INCONTINENCE 4 0.0001
834 NEOPLASM MALIGNANT 9 0.0001
835 URINARY TRACT INFECTION 23 0.0001
836 PULMONARY OEDEMA 6 0.0001
837 CHROMATURIA 3 0.0001
838 HYPOAESTHESIA ORAL 2 0.0001
839 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
840 COVID-19 23 0.0001
841 DRUG ADMINISTRATION ERROR 4 0.0001
842 DRUG EFFECT DECREASED 7 0.0001
843 MUSCULOSKELETAL CHEST PAIN 2 0.0001
844 COGNITIVE DISORDER 6 0.0001
845 CARDIAC DISORDER 12 0.0001
846 BASAL CELL CARCINOMA 2 0.0001
847 CYANOSIS 2 0.0001
848 ARRHYTHMIA 6 0.0001
849 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
850 MULTIPLE SCLEROSIS 6 0.0001
851 ABSCESS 2 0.0001
852 PHOTOSENSITIVITY REACTION 2 0.0001
853 AGEUSIA 3 0.0001
854 VIRAL INFECTION 4 0.0001
855 INJECTION SITE PRURITUS 8 0.0001
856 FACE OEDEMA 2 0.0001
857 FLUSHING 12 0.0001
858 CIRCULATORY COLLAPSE 2 0.0001
859 HYPOPHAGIA 3 0.0001
860 MUSCULOSKELETAL DISCOMFORT 2 0.0001
861 PARANOIA 2 0.0001
862 NEUROPATHY PERIPHERAL 11 0.0001
863 VAGINAL HAEMORRHAGE 5 0.0001
864 MENTAL DISORDER 5 0.0001
865 DEAFNESS 3 0.0001
866 LOCAL SWELLING 2 0.0001
867 BURNING SENSATION 8 0.0001
868 ANGIOEDEMA 5 0.0001
869 ATRIAL FIBRILLATION 11 0.0001
870 GALLBLADDER DISORDER 2 0.0001
871 JAUNDICE 3 0.0001
872 GOUT 2 0.0001
873 OSTEOMYELITIS 2 0.0001
874 VISION BLURRED 15 0.0001
875 SKIN DISCOLOURATION 5 0.0001
876 DIVERTICULITIS 3 0.0001
877 HEPATIC STEATOSIS 2 0.0001
878 DRUG INTERACTION 17 0.0001
879 RENAL IMPAIRMENT 9 0.0001
880 DYSARTHRIA 4 0.0001
881 DYSPNOEA EXERTIONAL 4 0.0001
882 BLOOD SODIUM DECREASED 2 0.0001
883 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
884 BLOOD URINE PRESENT 2 0.0001
885 GASTRIC ULCER 2 0.0001
886 POST PROCEDURAL COMPLICATION 2 0.0001
887 LIVER FUNCTION TEST ABNORMAL 3 0.0001
888 DYSPHONIA 6 0.0001
889 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
890 SURGERY 6 0.0001
891 KIDNEY INFECTION 2 0.0001
892 MENORRHAGIA 2 0.0001
893 ACUTE MYOCARDIAL INFARCTION 3 0.0001
894 HAEMATOCRIT DECREASED 2 0.0001
895 SYNCOPE 10 0.0001
896 IRRITABILITY 6 0.0001
897 BLOOD POTASSIUM DECREASED 3 0.0001
898 APHASIA 3 0.0001
899 FEEDING DISORDER 2 0.0001
900 DYSKINESIA 4 0.0001
901 INJECTION SITE RASH 3 0.0001
902 DEHYDRATION 13 0.0001
903 INFLUENZA LIKE ILLNESS 8 0.0001
904 PULMONARY HYPERTENSION 2 0.0001
905 PRODUCT DOSE OMISSION ISSUE 28 0.0001
906 RENAL FAILURE ACUTE 4 0.0001
907 FAECES DISCOLOURED 2 0.0001
908 STAPHYLOCOCCAL INFECTION 3 0.0001
909 EMOTIONAL DISTRESS 11 0.0001
910 VISUAL ACUITY REDUCED 3 0.0001
911 RASH MACULO-PAPULAR 2 0.0001
912 OXYGEN SATURATION DECREASED 5 0.0001
913 ANGER 3 0.0001
914 HEART RATE IRREGULAR 2 0.0001
915 PRODUCT AVAILABILITY ISSUE 2 0.0001
916 INJECTION SITE BRUISING 7 0.0001
917 CARDIAC FAILURE CONGESTIVE 7 0.0001
918 BONE PAIN 5 0.0001
919 ACUTE KIDNEY INJURY 13 0.0001
920 COMA 4 0.0001
921 BLOOD GLUCOSE DECREASED 4 0.0001
922 LOCALISED INFECTION 2 0.0001
923 CEREBRAL INFARCTION 2 0.0001
924 ENCEPHALOPATHY 2 0.0001
925 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
926 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
927 HEPATIC FUNCTION ABNORMAL 3 0.0001
928 UNEVALUABLE EVENT 6 0.0001
929 ACNE 6 0.0001
930 DEVICE ISSUE 7 0.0001
931 HAEMATOMA 2 0.0001
932 EXPOSURE VIA SKIN CONTACT 2 0.0001
933 SPEECH DISORDER 4 0.0001
934 APPLICATION SITE ERYTHEMA 2 0.0001
935 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
936 GASTRITIS 2 0.0001
937 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
938 ABNORMAL BEHAVIOUR 3 0.0001
939 BLOOD PRESSURE DECREASED 5 0.0001
940 INJECTION SITE PAIN 23 0.0001
941 DRY SKIN 10 0.0001
942 PAIN OF SKIN 2 0.0001
943 NEUTROPHIL COUNT DECREASED 3 0.0001
944 PNEUMONITIS 2 0.0001
945 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
946 LUNG NEOPLASM MALIGNANT 3 0.0001
947 INJECTION SITE ERYTHEMA 9 0.0001
948 RHABDOMYOLYSIS 3 0.0001
949 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
950 SEPSIS 8 0.0001
951 CEREBROVASCULAR ACCIDENT 12 0.0001
952 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
953 RENAL INJURY 2 0.0001
954 CATARACT 4 0.0001
955 PREMATURE BABY 2 0.0001
956 HOT FLUSH 5 0.0001
957 HEPATIC FAILURE 2 0.0001
958 PLATELET COUNT DECREASED 7 0.0001
959 NEPHROLITHIASIS 3 0.0001
960 INJECTION SITE SWELLING 5 0.0001
961 NERVOUS SYSTEM DISORDER 2 0.0001
962 DRUG DEPENDENCE 10 0.0001
963 CHOLELITHIASIS 2 0.0001
964 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
965 THERAPY CESSATION 3 0.0001
966 BLOOD GLUCOSE INCREASED 11 0.0001
967 BRADYCARDIA 3 0.0001
968 THERAPY INTERRUPTED 4 0.0001
969 CEREBRAL HAEMORRHAGE 2 0.0001
970 CRYING 2 0.0001
971 DEPENDENCE 3 0.0001
972 INJECTION SITE MASS 2 0.0001
973 PRODUCT SUBSTITUTION ISSUE 3 0.0001
974 MYOCARDIAL INFARCTION 9 0.0001
975 ABORTION SPONTANEOUS 2 0.0000
976 CARDIAC FAILURE 4 0.0000
977 DEVICE BREAKAGE 2 0.0000
978 BLINDNESS 2 0.0000
979 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
980 CARDIAC ARREST 4 0.0000
981 HYPOACUSIS 2 0.0000
982 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
983 HYPOGLYCAEMIA 2 0.0000
984 PRODUCT DOSE OMISSION 2 0.0000
985 DEVICE MALFUNCTION 2 0.0000
986 DRUG WITHDRAWAL SYNDROME 2 0.0000
987 BREAST CANCER 2 0.0000
988 DISEASE PROGRESSION 2 0.0000
989 DRUG DOSE OMISSION 2 0.0000